Amarin Corp. Plc
(NASDAQ : AMRN)

( )
AMRN PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
MDCOMedicines Company
-2.46%47.5020.3%$144.62m
VRXValeant Pharmaceuticals International, Inc.
0.47%23.3514.1%$137.39m
AMRNAmarin Corporation Plc Sponsored ADR
0.58%17.351.8%$107.12m
PRGOPerrigo Co. Plc
1.29%56.686.8%$63.94m
JAZZJazz Pharmaceuticals Plc
1.98%134.012.3%$63.68m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-2.82%137.036.2%$59.04m
SAGESAGE Therapeutics, Inc.
3.48%165.358.6%$58.81m
ENDPEndo International Plc
2.14%4.298.8%$45.48m
CTLTCatalent Inc
-1.46%50.602.4%$43.11m
MNKMallinckrodt Plc
2.99%3.1020.9%$42.78m
ICPTIntercept Pharmaceuticals, Inc.
4.86%72.2516.9%$32.57m
UTHRUnited Therapeutics Corporation
3.52%83.5314.3%$32.45m
AERIAerie Pharmaceuticals, Inc.
7.92%23.846.8%$29.31m
ICLRICON Plc
0.35%150.444.1%$28.60m
PTLAPortola Pharmaceuticals, Inc.
1.53%31.156.7%$28.57m

Company Profile

Amarin Corp. Plc is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. Its product development program leverages its experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. It has developed and markets Vascepa capsules through wholesale. The company was founded by Geoffrey W. Guy on March 1, 1989 and is headquartered in Dublin, Ireland.